Correlation Between Akari Therapeutics and Pulmatrix
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Pulmatrix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Pulmatrix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and Pulmatrix, you can compare the effects of market volatilities on Akari Therapeutics and Pulmatrix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Pulmatrix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Pulmatrix.
Diversification Opportunities for Akari Therapeutics and Pulmatrix
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Akari and Pulmatrix is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Pulmatrix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pulmatrix and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Pulmatrix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pulmatrix has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Pulmatrix go up and down completely randomly.
Pair Corralation between Akari Therapeutics and Pulmatrix
Given the investment horizon of 90 days Akari Therapeutics PLC is expected to under-perform the Pulmatrix. But the stock apears to be less risky and, when comparing its historical volatility, Akari Therapeutics PLC is 1.8 times less risky than Pulmatrix. The stock trades about -0.26 of its potential returns per unit of risk. The Pulmatrix is currently generating about 0.34 of returns per unit of risk over similar time horizon. If you would invest 209.00 in Pulmatrix on August 29, 2024 and sell it today you would earn a total of 420.00 from holding Pulmatrix or generate 200.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akari Therapeutics PLC vs. Pulmatrix
Performance |
| Timeline |
| Akari Therapeutics PLC |
| Pulmatrix |
Akari Therapeutics and Pulmatrix Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akari Therapeutics and Pulmatrix
The main advantage of trading using opposite Akari Therapeutics and Pulmatrix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Pulmatrix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pulmatrix will offset losses from the drop in Pulmatrix's long position.| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
| Pulmatrix vs. Capricor Therapeutics | Pulmatrix vs. Soleno Therapeutics | Pulmatrix vs. Bio Path Holdings | Pulmatrix vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |